Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission

Blood

Volumn 121, Issue 7, 2013, Pages 1157-1164

  Jennes, Wim ^a   Verheyden, Sonja ^b   Mertens, Julie W ^a   Camara, Makhtar ^c   Seydi, Moussa ^c   Dieye, Tandakha N ^c   Mboup, Souleymane ^c   Demanet, Christian ^b   Kestens, Luc ^a,d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c Centre Hospitalier Universitaire Dakar   (Senegal)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADULT; AFRICA; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL KILLING; COCULTURE; CONTROLLED STUDY; FEMALE; HLA SYSTEM; HLA TYPING; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECIPIENT; SEXUALITY; VIRUS TRANSMISSION;

EID: 84874058412     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-455352     Document Type: Article

References (50)

1. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008; 9(5):503-510. (Pubitemid 351560519)
2. Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol. 2011; 89(2):216-224.
3. Middleton D, Gonzelez F. The extensive polymorphism of KIR genes. Immunology. 2010;129(1):8-19.
4. Biassoni R, Ugolotti E, De MA. NK cell receptors and their interactions with MHC. Curr Pharm Des. 2009;15(28):3301-3310.
5. Hoglund P, Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol. 2010;10(10):724-734.
6. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5(3):201-214. (Pubitemid 40364822)
7. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008;20(6):343-352.
8. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
9. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007;110(1):433-440. (Pubitemid 47026866)
10. Pende D, Marcenaro S, Falco M, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pedi-atric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood. 2009;113(13):3119-3129.
11. Moretta L, Locatelli F, Pende D, et al. Killer Ig-like receptor-mediated control of natural killer cell al-loreactivity in haploidentical hematopoietic stem cell transplantation. Blood. 2011;117(3):764-771.
12. van Bergen J, Thompson A, Haasnoot GW, et al. KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant. 2011; 11(9):1959-1964.
13. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9(2):118-129.
14. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis. 2005;191(Suppl 1):S68-S77. (Pubitemid 40144231)
15. MacDonald KS, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 1998;177(3):551-556. (Pubitemid 28099866)
16. Lockett SF, Robertson JR, Brettle RP, et al. Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. J Acquir Immune Defic Syndr. 2001;27(3):277-280. (Pubitemid 32661970)
17. Polycarpou A, Ntais C, Korber BT, et al. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses. 2002;18(11):741-746.
18. Dorak MT, Tang J, Penman-Aguilar A, et al. Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. Lancet. 2004;363(9427):2137-2139. (Pubitemid 38844156)
19. Mackelprang RD, John-Stewart G, Carrington M, et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis. 2008; 197(8):1156-1161. (Pubitemid 351590051)
20. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31(4):429-434. (Pubitemid 35154456)
21. Gaudieri S, DeSantis D, McKinnon E, et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 2005;6(8): 683-690. (Pubitemid 41741713)
22. Lopez-Vazquez A, Mina-Blanco A, Martinez-Borra J, et al. Interaction between KIR3DL1 and HLA-B&z. ast;57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol. 2005;66(3):285-289. (Pubitemid 40395248)
23. Qi Y, Martin MP, Gao X, et al. KIR/HLApleiotro-pism: protection against both HIV and opportunistic infections. PLoS Pathog. 2006;2(8):e79.
24. Barbour JD, Sriram U, Caillier SJ, et al. Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 2007;3(4): e43.
25. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39(6):733-740. (Pubitemid 46848586)
26. Jennes W, Verheyden S, Demanet C, et al. Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands. PLoS One. 2011;6(2):e17043.
27. Pelak K, Need AC, Fellay J, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 2011;9(11):e1001208.
28. Jennes W, Verheyden S, Demanet C, et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLAligands. J Immunol. 2006;177(10):6588-6592. (Pubitemid 44715020)
29. Ravet S, Scott-Algara D, Bonnet E, et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood. 2007; 109(10):4296-4305. (Pubitemid 46743396)
30. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS. 2008;22(5):595-599. (Pubitemid 351640592)
31. Boulet S, Kleyman M, Kim JY, et al. Acombined genotype of KIR3DL1 high expressing alleles and HLA-B&z. ast;57 is associated with a reduced risk of HIV infection. AIDS. 2008;22(12):1487-1491.
32. Guerini FR, Lo CS, Gori A, et al. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1 +/BW4+ complex in HIV exposed seronegative individuals. J Infect Dis. 2011;203(9): 1235-1239.
33. Paximadis M, Minevich G, Winchester R, et al. KIR-HLAand maternal-infant HIV-1 transmission in sub-Saharan Africa. PLoS One. 2011;6(2): e16541.
34. Merino A, Malhotra R, Morton M, et al. Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples. J Infect Dis. 2011;203(4):487-495.
35. Jennes W, Kyongo JK, Vanhommerig E, et al. Molecular epidemiology of HIV-1 transmission in a cohort of HIV-1 concordant heterosexual couples from Dakar, Senegal. PLoS One. 2012; 7(5):e37402.
36. Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol. 2002;22(5-6):463-482.
37. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
38. Anderson DJ, Politch JA, Nadolski AM, et al. Targeting Trojan horse leukocytes for HIV prevention. AIDS. 2010;24(2):163-187.
39. Salle B, Brochard P, Bourry O, et al. Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis. 2010; 202(3):337-344.
40. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med. 2007;204(12):3027-3036. (Pubitemid 350179568)
41. Scott-Algara D, Truong LX, Versmisse P, et al. Cutting edge: increased NKcell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol. 2003;171(11):5663-5667. (Pubitemid 37467178)
42. Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006;120(2):138-146. (Pubitemid 44080673)
43. Tomescu C, Duh FM, Lanier MA, et al. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS. 2010;24(14):2151-2160.
44. Naranbhai V, Altfeld M, Karim QA, et al. Natural killer cell function in women at high risk for HIV acquisition: Insights from the CAPRISA004 mi-crobicide trial. AIDS. 2012;26(14):1745-1753.
45. Verheyden S, Schots R, Duquet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia. 2005;19(8):1446-1451. (Pubitemid 41136340)
46. Venstrom JM, Pittari G, Gooley TA, et al. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med. 2012; 367(9):805-816.
47. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood. 2010;115(6):1166-1174.
48. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191(9):1403-1409. (Pubitemid 40563350)
49. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010; 362(5):427-439.
50. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3(77):77ra29.